SEC Form D filing

Fairfield Bio, Inc., 2026-02-12

An SEC Form D private-offering notice from Bronx, NY, a $2,000,000 filer-stated offering target in Biotech. Filed 2026-02-12. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Fairfield Bio, Inc. site↗ Verified via SEC Form D

Operates a marketplace connecting non-human genomic data providers with researchers and commercial users, using contractual data sharing terms.

Filed 2026-02-12Filed to raise $2,000,000First money in 2026-01-26Raised so far $450,000HQ (as filed) Bronx, NYSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified fairfieldbio.com↗Named in the filing 2 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source